Coffee's main plant compound, sold as green coffee extract. Controlled human research shows blood pressure, fasting blood sugar, total cholesterol and body weight edge downward — but only where starting values are already above target. Sharper thinking and a healthier liver failed in people; longer life rests on animal work. It binds iron; half of tested products missed their labeled amounts. (Full Review)

Protocol

Standard protocol — standardized extract

200–400 mg chlorogenic acid daily

Delivered as 400–800 mg green coffee extract standardized to 45–50%. Examine places the useful range at 120–300 mg.

Best time of day

With the largest carbohydrate meal

Morning dosing is standard in trials; trials using non-decaffeinated extracts kept dosing before mid-afternoon.

Single versus split dosing

Single daily dose

Splitting across two meals is used where the aim is blunting post-meal glucose at both, and may also reduce nausea.

Time to effect

Blood pressure

4–12 weeks

Acute vessel widening is measurable within hours of a single dose.

Fasting glucose

4–12 weeks

Fasting glucose changes appear in the same four-to-twelve-week trial window as blood pressure.

Body weight

8–12 weeks

Weight changes take eight to twelve weeks and stay small.

Benefits

High: Reduced blood pressure; lower fasting blood glucose and insulin; modest reduction in body weight

Medium: Improved endothelial function; lower total cholesterol; improved skin barrier function and skin microcirculation

Low: Lower C-reactive protein; improved cognitive performance; increased postprandial fat oxidation; reduced liver fat; improved mood; antitumor activity

Speculative: Extension of lifespan in model organisms; improved systemic antioxidant capacity

Contraindications

Diagnosed iron-deficiency anemia, ferritin below 30 ng/mL, or active oral or intravenous iron repletion

Known allergy to coffee or to green coffee bean protein, including occupational coffee-dust sensitization

Pregnancy and breastfeeding

Low resting blood pressure (systolic below 100 mmHg) or symptomatic drops in pressure on standing

Homocystinuria, or untreated homocysteine above 15 μmol/L with low folate or vitamin B12

Children and adolescents under 18 years

Key Interactions

Blood-pressure-lowering drugs (amlodipine, lisinopril, losartan)

Glucose-lowering drugs (metformin, glipizide, insulin)

Oral iron supplements (ferrous sulfate, ferrous bisglycinate)

Antiplatelet and anticoagulant drugs (aspirin, clopidogrel, warfarin)

Over-the-counter caffeine products (caffeine tablets, energy drinks, pre-workout blends)

Over-the-counter antacids and proton pump inhibitors (calcium carbonate, omeprazole)

Supplements that also lower blood pressure (beetroot nitrate, hibiscus extract, magnesium, aged garlic extract)

Supplements that also lower blood glucose (berberine, alpha-lipoic acid, cinnamon extract, chromium)

Polyphenol-rich supplements and beverages (green tea extract, tannin-rich black tea)

Bariatric surgery and ketogenic or very-low-carbohydrate diets

Risk & Side Effects

Medium: Reduced non-heme iron absorption; injection-site induration with the investigational injectable form; allergic sensitization to green coffee bean material

Low: Elevated plasma homocysteine; nausea, upset stomach and headache; additive blood-pressure and glucose lowering; caffeine load from non-decaffeinated extracts

Speculative: Pro-oxidant activity at high concentrations; reduced absorption of other trace minerals

Monitoring

Marker	Target	Why
Home Blood Pressure	110–120 / 70–75 mmHg	The primary measurable effect
Fasting Blood Glucose	75–86 mg/dL	Second measurable effect; detects additive lowering with medication
Fasting Insulin	2–5 μIU/mL	Falls alongside glucose in pooled trials
HbA1c	4.8–5.3%	Confirms whether a fasting change persists over months
Ferritin	50–125 ng/mL (women), 75–150 ng/mL (men)	The marker this compound moves downward
Total Homocysteine	5–8 μmol/L	The one adverse biochemical change shown in a controlled trial
Total Cholesterol and Lipid Panel	Total 160–200 mg/dL; LDL below 100 mg/dL	Small reproducible reduction in total cholesterol
Liver Enzymes (ALT, AST)	ALT 10–26 U/L, AST 10–26 U/L	Safety check on extract products of uncertain purity
eGFR	Above 90 mL/min/1.73 m²	Baseline organ function before sustained supplement use
Body Weight and Waist Circumference	Waist below 35 in (women) or 40 in (men); otherwise change from the individual's own baseline	Tracks the weight effect, which is small

Cadence: Home blood pressure daily for the first two weeks, then weekly to week four, then monthly; fasting glucose at four and twelve weeks; ferritin, homocysteine and the lipid panel at twelve weeks, then every six to twelve months while intake continues.

Qualitative Assessment

Post-meal energy stability: less of the mid-afternoon slump after starch-heavy meals
Sleep onset and continuity: the first thing to change if the extract retains caffeine
Cold hands, breathlessness on stairs, unusual fatigue: the lived experience of falling iron stores
Dizziness on standing: the signal that blood-pressure lowering has gone too far alongside medication
Digestive comfort: nausea, loose stools or bloating in the first two weeks

Chlorogenic Acid for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment